ArticleRadiology case reports2025
Detection of a contralateral breast malignancy using contrast-enhanced mammography (CEM) overlooked by initial MRI scan.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-enhanced mammography (CEM) has emerged as a promising technology in the field of breast imaging, experiencing growing acceptance. However, the comparative evaluation of its diagnostic accuracy against MRI remains sparse, largely attributed to its relatively recent introduction. Current studies suggest that MRI and CEM exhibit comparable sensitivity for detecting the index breast lesion. However, there is conflicting evidence regarding their sensitivity in detecting additional breast lesions in cases of known breast cancer, with some studies demonstrating MRI's superiority and others reporting similar sensitivity between the 2 modalities. We present a case where CEM effectively detected a contralateral breast malignancy in a patient with a newly diagnosed breast cancer, whereas it went undetected by MRI initially. Our presentation underscores the importance of more comprehensive research to assess CEM's overall diagnostic capabilities in breast imaging in comparison to MRI, as there may be situations where CEM outperforms MRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.